Hurley Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Hurley Capital's IBB Position: Q3 2026 in Review
Hurley Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 290 shares worth $61.1K. The position accounts for 0.03% of the portfolio, ranked #181.
Hurley Capital first reported a position in IBB in Q4 2024 and has held it in 8 quarters since. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Hurley Capital held 290 shares of iShares Biotechnology ETF worth $61.1K as of Q3 2026.
- Hurley Capital left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.03% of Hurley Capital's portfolio in Q3 2026, its #181 holding.
- Hurley Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 8 quarters since.
- 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.